Literature DB >> 15452216

Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome.

Susan M Varnum1, Daniel N Streblow, Matthew E Monroe, Patricia Smith, Kenneth J Auberry, Ljiljana Pasa-Tolic, Dai Wang, David G Camp, Karin Rodland, Steven Wiley, William Britt, Thomas Shenk, Richard D Smith, Jay A Nelson.   

Abstract

Human cytomegalovirus (HCMV), a member of the herpesvirus family, is a large complex enveloped virus composed of both viral and cellular gene products. While the sequence of the HCMV genome has been known for over a decade, the full set of viral and cellular proteins that compose the HCMV virion are unknown. To approach this problem we have utilized gel-free two-dimensional capillary liquid chromatography-tandem mass spectrometry (MS/MS) and Fourier transform ion cyclotron resonance MS to identify and determine the relative abundances of viral and cellular proteins in purified HCMV AD169 virions and dense bodies. Analysis of the proteins from purified HCMV virion preparations has indicated that the particle contains significantly more viral proteins than previously known. In this study, we identified 71 HCMV-encoded proteins that included 12 proteins encoded by known viral open reading frames (ORFs) previously not associated with virions and 12 proteins from novel viral ORFs. Analysis of the relative abundance of HCMV proteins indicated that the predominant virion protein was the pp65 tegument protein and that gM rather than gB was the most abundant glycoprotein. We have also identified over 70 host cellular proteins in HCMV virions, which include cellular structural proteins, enzymes, and chaperones. In addition, analysis of HCMV dense bodies indicated that these viral particles are composed of 29 viral proteins with a reduced quantity of cellular proteins in comparison to HCMV virions. This study provides the first comprehensive quantitative analysis of the viral and cellular proteins that compose infectious particles of a large complex virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452216      PMCID: PMC521840          DOI: 10.1128/JVI.78.20.10960-10966.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Authors:  Dong Yu; Maria C Silva; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

2.  Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry.

Authors:  Edwin Lasonder; Yasushi Ishihama; Jens S Andersen; Adriaan M W Vermunt; Arnab Pain; Robert W Sauerwein; Wijnand M C Eling; Neil Hall; Andrew P Waters; Hendrik G Stunnenberg; Matthias Mann
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

3.  Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags.

Authors:  Mary S Lipton; Ljiljana Pasa-Tolic'; Gordon A Anderson; David J Anderson; Deanna L Auberry; John R Battista; Michael J Daly; Jim Fredrickson; Kim K Hixson; Heather Kostandarithes; Christophe Masselon; Lye Meng Markillie; Ronald J Moore; Margaret F Romine; Yufeng Shen; Eric Stritmatter; Nikola Tolic'; Harold R Udseth; Amudhan Venkateswaran; Kwong-Kwok Wong; Rui Zhao; Richard D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

4.  Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A.

Authors:  S Michelson; P Turowski; L Picard; J Goris; M P Landini; A Topilko; B Hemmings; C Bessia; A Garcia; J L Virelizier
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 5.  Structure and assembly of the virion.

Authors:  W Gibson
Journal:  Intervirology       Date:  1996       Impact factor: 1.763

6.  Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts.

Authors:  J F Wright; A Kurosky; E L Pryzdial; S Wasi
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  Direct analysis of protein complexes using mass spectrometry.

Authors:  A J Link; J Eng; D M Schieltz; E Carmack; G J Mize; D R Morris; B M Garvik; J R Yates
Journal:  Nat Biotechnol       Date:  1999-07       Impact factor: 54.908

8.  Neutralization of human cytomegalovirus by human CD13-specific antibodies.

Authors:  T D Giugni; C Söderberg; D J Ham; R M Bautista; K O Hedlund; E Möller; J A Zaia
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

9.  Virion basic phosphoprotein from human cytomegalovirus contains O-linked N-acetylglucosamine.

Authors:  D M Benko; R S Haltiwanger; G W Hart; W Gibson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  A proteomic view of the Plasmodium falciparum life cycle.

Authors:  Laurence Florens; Michael P Washburn; J Dale Raine; Robert M Anthony; Munira Grainger; J David Haynes; J Kathleen Moch; Nemone Muster; John B Sacci; David L Tabb; Adam A Witney; Dirk Wolters; Yimin Wu; Malcolm J Gardner; Anthony A Holder; Robert E Sinden; John R Yates; Daniel J Carucci
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

View more
  308 in total

Review 1.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

2.  Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response.

Authors:  Jayme Salsman; Madhav Jagannathan; Patrick Paladino; Pak-Kei Chan; Graham Dellaire; Brian Raught; Lori Frappier
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.

Authors:  Kevin B Spurgers; Tim Alefantis; Brian D Peyser; Gordon T Ruthel; Alison A Bergeron; Julie A Costantino; Sven Enterlein; Krishna P Kota; R C Dutch Boltz; M Javad Aman; Vito G Delvecchio; Sina Bavari
Journal:  Mol Cell Proteomics       Date:  2010-08-11       Impact factor: 5.911

4.  RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection.

Authors:  Matthew S Miller; Wendy E Furlong; Leesa Pennell; Marc Geadah; Laura Hertel
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

5.  Recruitment of herpes simplex virus type 1 immediate-early protein ICP0 to the virus particle.

Authors:  Kevin Maringer; Gillian Elliott
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

Review 6.  Role of tegument proteins in herpesvirus assembly and egress.

Authors:  Haitao Guo; Sheng Shen; Lili Wang; Hongyu Deng
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

7.  Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance.

Authors:  Uzoma K Iheagwara; Pamela L Beatty; Phu T Van; Ted M Ross; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2013-12-05       Impact factor: 11.151

8.  Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.

Authors:  Rike Webel; Morgan Hakki; Mark N Prichard; William D Rawlinson; Manfred Marschall; Sunwen Chou
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.

Authors:  Vasvi Tripathi; Kiran Sankar Chatterjee; Ranabir Das
Journal:  J Biol Chem       Date:  2019-08-01       Impact factor: 5.157

10.  Restriction of Human Cytomegalovirus Infection by Galectin-9.

Authors:  Allison Abendroth; Brian P McSharry; Barry Slobedman; Emily A Machala; Selmir Avdic; Lauren Stern; Dirk M Zajonc; Chris A Benedict; Emily Blyth; David J Gottlieb
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.